Shuttle Pharmaceuticals Holdings Operating Expenses Growth & History (SHPH)
Shuttle Pharmaceuticals Holdings's operating expenses was $11.9M for fiscal 2025.
View full Shuttle Pharmaceuticals Holdings company overviewShuttle Pharmaceuticals Holdings annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $11.9M | $4.2M | +54.84% |
| 2024 | 2024-12-31 | $7.7M | $1.8M | +30.61% |
| 2023 | 2023-12-31 | $5.9M | $3.5M | +151.40% |
| 2022 | 2022-12-31 | $2.3M | $600,834 | +34.47% |
| 2021 | 2021-12-31 | $1.7M | — | — |
Shuttle Pharmaceuticals Holdings quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $2.2M | −$734,419 | −24.89% |
| Q4 2025 | 2025-12-31 | $2.8M | $1.0M | +56.90% |
| Q3 2025 | 2025-09-30 | $2.3M | −$784,619 | −25.71% |
| Q2 2025 | 2025-06-30 | $3.9M | $2.4M | +163.75% |
| Q1 2025 | 2025-03-31 | $3.0M | $1.6M | +113.11% |
| Q4 2024 | 2024-12-31 | $1.8M | $494,304 | +38.53% |
| Q3 2024 | 2024-09-30 | $3.1M | $1.5M | +90.82% |
| Q2 2024 | 2024-06-30 | $1.5M | $17,002 | +1.16% |
| Q1 2024 | 2024-03-31 | $1.4M | −$159,933 | −10.35% |
| Q4 2023 | 2023-12-31 | $1.3M | $752,488 | +141.89% |
| Q3 2023 | 2023-09-30 | $1.6M | $777,678 | +94.67% |
| Q2 2023 | 2023-06-30 | $1.5M | $1.1M | +314.46% |
| Q1 2023 | 2023-03-31 | $1.5M | $906,384 | +141.98% |
| Q4 2022 | 2022-12-31 | $530,336 | — | — |
| Q3 2022 | 2022-09-30 | $821,468 | $579,352 | +239.29% |
| Q2 2022 | 2022-06-30 | $353,626 | — | — |
| Q1 2022 | 2022-03-31 | $638,396 | — | — |
| Q3 2021 | 2021-09-30 | $242,116 | — | — |
Shuttle Pharmaceuticals Holdings operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, Shuttle Pharmaceuticals Holdings's operating expenses increased from $1.7M to $11.9M, a change of $10.2M. The latest reported quarter, Q1 2026, shows $2.2M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Shuttle Pharmaceuticals Holdings source filings ↗